Member

Ewa KOPACZ

EPP · Poland

Group: EPP PPE
Country: Poland
Roll-call participation: 99.4 %ⓘ of 2 891 roll calls in office · chamber median 91.2 % · 2025, roll calls
With majority line: 90.3 %ⓘ of 2 874 votes where the group had a line · EPP median 93.5 %

More facts (5)

National party: KO Koalicja Obywatelska
In office: Since 16 Jul 2024
Against clear line: 204 of 2 736 votesⓘ
Committees: ENVI, FEMM, SANT (substitute)
Member id: 197525

National party: KO Koalicja Obywatelska
In office: Since 16 Jul 2024
Against clear line: 204 of 2 736 votesⓘ
Committees: ENVI, FEMM, SANT (substitute)
Member id: 197525

Cite this page

EP profile

Link to this page

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Period Whole term 2024 (from July)2025 2026

Custom dates

Votes Final votes293 All roll calls2 891

Roll-call participation ⓘ

99.4 %

2 874 of 2 891 roll calls while in office

EPP median: 91.0 % (+8.4 pts)

Chamber median: 91.2 %

With majority line ⓘ

90.3 %

2 596 of 2 874 votes where their group had a line

EPP median: 93.5 % (−3.2 pts)

Against clear line ⓘ

7.5 %

204 of 2 736 votes where their group had a clear line

162 opposite (for ↔ against), 42 abstained against the line

Abstention ⓘ

2.1 %

61 of 2 874 votes cast

Participation 99.4 % — EPP median 91.0 %, 187 members.ⓘ

Data as a table

Participation among the 187 members of the EPP with enough votes.
Figure	Participation
Ewa KOPACZ	99.4 %
EPP median	91.0 %
Lowest in the group	23.2 %
Highest in the group	99.7 %
Members	187

With majority line 90.3 % — EPP median 93.5 %, 187 members.ⓘ

Data as a table

With majority line among the 187 members of the EPP with enough votes.
Figure	With majority line
Ewa KOPACZ	90.3 %
EPP median	93.5 %
Lowest in the group	66.7 %
Highest in the group	98.9 %
Members	187

2025, 2 891 roll-call votes. The dots are the other members of EPP; no ranks.
“No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Show Final votes All roll calls

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
Date	Decision	Result	Position	Majority line
17 Sept 2026	Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung	Adopted 459 for, 12 against, 86 abstained	Position: For	Majority line: For
17 Sept 2026	Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro	Adopted 374 for, 198 against, 19 abstained	Position: For	Majority line: For
17 Sept 2026	An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector	Adopted 514 for, 61 against, 33 abstained	Position: For	Majority line: For
17 Sept 2026	Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya	Adopted 562 for, 1 against, 33 abstained	Position: For	Majority line: For
17 Sept 2026	Impact of social media and the online environment on young people	Adopted 395 for, 136 against, 80 abstained	Position: For	Majority line: For
17 Sept 2026	The role of social, economic and environmental standards in safeguarding fair competition for all aquatic food products and improving food security	Adopted 467 for, 92 against, 44 abstained	Position: For	Majority line: For
17 Sept 2026	Evaluation of the Common Fisheries Policy and follow-up	Adopted 368 for, 172 against, 69 abstained	Position: For	Majority line: For
17 Sept 2026	Narco-trafficking in Europe’s waters: protecting our borders and supporting our law enforcement officers	Adopted 601 for, 4 against, 5 abstained	Position: For	Majority line: For
17 Sept 2026	The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect EU’s external borders	Adopted 339 for, 225 against, 16 abstained	Position: For	Majority line: For
17 Sept 2026	Strengthening global health resilience in partner countries	Adopted 319 for, 142 against, 19 abstained	Position: For	Majority line: For
16 Sept 2026	Simplification of intra-EU transfers of defence-related products and simplification of security and defence procurement (Omnibus V)	Passed 549 for, 92 against, 27 abstained	Position: For	Majority line: For
16 Sept 2026	Acceleration of permit-granting for defence readiness projects (Omnibus V)	Passed 540 for, 105 against, 22 abstained	Position: For	Majority line: For
16 Sept 2026	Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V)	Passed 530 for, 125 against, 12 abstained	Position: For	Majority line: For
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034	Passed 496 for, 53 against, 125 abstained	Position: For	Majority line: For
16 Sept 2026	Instrument for Nuclear Safety Cooperation 2028-2034	Passed 600 for, 21 against, 48 abstained	Position: For	Majority line: For
16 Sept 2026	Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034	Passed 625 for, 20 against, 22 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime	Consent given 549 for, 75 against, 30 abstained	Position: For	Majority line: For
16 Sept 2026	EU-UK Agreement regarding cooperation on the application of their respective competition laws	Consent given 640 for, 5 against, 26 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme	Consent given 631 for, 7 against, 15 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme	Consent given 612 for, 8 against, 16 abstained	Position: For	Majority line: For
16 Sept 2026	Genetically modified soybean GMB151 x DAS-44406-6	Objection passed 442 for, 184 against, 12 abstained	Position: Against	Majority line: Against
16 Sept 2026	Genetically modified soybean MON 94313	Objection passed 457 for, 184 against, 10 abstained	Position: Against	Majority line: Against
16 Sept 2026	Genetically modified maize MON 87460	Objection passed 433 for, 159 against, 10 abstained	Position: Against	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure	Adopted 470 for, 129 against, 62 abstained	Position: For	Majority line: For
16 Sept 2026	An EU cardiovascular diseases strategy	Adopted 545 for, 47 against, 75 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions	Adopted 390 for, 218 against, 29 abstained	Position: For	Majority line: Against
15 Sept 2026	Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measures	Passed 464 for, 50 against, 159 abstained	Position: For	Majority line: For
15 Sept 2026	Establishing the Temporary Decarbonisation Fund	Passed 433 for, 97 against, 146 abstained	Position: Abstained ≠ group	Majority line: For
15 Sept 2026	Market stability reserve for the EU Emissions Trading System (EU ETS): ceasing the invalidation of allowances	Passed 367 for, 240 against, 59 abstained	Position: For	Majority line: For
15 Sept 2026	Market stability reserve for the buildings, road transport and additional sectors	Passed 467 for, 158 against, 41 abstained	Position: For	Majority line: For
15 Sept 2026	Implementation into Union law of measures adopted by regional fisheries management organisations	Passed 559 for, 48 against, 62 abstained	Position: For	Majority line: For
15 Sept 2026	General Fisheries Commission for the Mediterranean (GFCM): fishing in the GFCM Agreement area	Passed 580 for, 51 against, 39 abstained	Position: For	Majority line: For
15 Sept 2026	Temporary trade-liberalisation measures applicable to Armenian products	Passed 583 for, 49 against, 39 abstained	Position: For	Majority line: For
15 Sept 2026	Draft amending budget No 2/2026: update of revenue (own resources) and adjustments to expenditure	Passed 440 for, 127 against, 104 abstained	Position: For	Majority line: For
15 Sept 2026	Findings and recommendations of the Special Committee on the European Democracy Shield	Adopted 420 for, 220 against, 26 abstained	Position: For	Majority line: For
15 Sept 2026	Implementation of the Council Recommendation on a Bridge to Jobs – Reinforcing the Youth Guarantee	Adopted 530 for, 77 against, 61 abstained	Position: For	Majority line: For
15 Sept 2026	The EU Youth Strategy 2019–2027	Adopted 477 for, 124 against, 66 abstained	Position: For	Majority line: For
15 Sept 2026	Global role of the euro	Adopted 405 for, 146 against, 60 abstained	Position: For	Majority line: For
9 Jul 2026	Establishment of the digital euro	Negotiating mandate approved 416 for, 169 against, 22 abstained	Position: Abstained ≠ group	Majority line: For
9 Jul 2026	The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan	Adopted 476 for, 28 against, 96 abstained	Position: For	Majority line: For
9 Jul 2026	Ongoing persecution of Christians in Nigeria, notably the Kawel village massacre	Adopted 510 for, 1 against, 86 abstained	Position: For	Majority line: For
9 Jul 2026	Feasibility of a 28th tax regime and its potential to support EU competitiveness	Adopted 366 for, 192 against, 39 abstained	Position: For	Majority line: For
8 Jul 2026	EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement	Consent given 479 for, 119 against, 65 abstained	Position: For	Majority line: For
8 Jul 2026	Protection of the environment through criminal law	Consent given 499 for, 99 against, 69 abstained	Position: For	Majority line: For
8 Jul 2026	EU–Mexico Interim Agreement on Trade	Consent given 474 for, 131 against, 60 abstained	Position: For	Majority line: For
8 Jul 2026	EU–Morocco Euro-Mediterranean Aviation Agreement: accession to the EU of Croatia (Protocol)	Consent given 625 for, 16 against, 20 abstained	Position: For	Majority line: For
8 Jul 2026	EU-Morocco Agreement for scientific and technological cooperation setting out the terms and conditions for the participation of Morocco in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA): amendment and supplement	Consent given 573 for, 35 against, 37 abstained	Position: For	Majority line: For
8 Jul 2026	Trajectory to decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets	Objection passed 388 for, 248 against, 24 abstained	Position: For	Majority line: For
8 Jul 2026	Lead in certain fishing tackle	Objection failed 197 for, 455 against, 7 abstained	Position: Against	Majority line: Against
8 Jul 2026	Genetically modified maize NK603 × T25	Objection passed 460 for, 189 against, 14 abstained	Position: Against	Majority line: Against

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 1 of 51 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Roll calls held at each sitting while in office and how many of them the member voted in.
Sitting	Roll calls	Voted in
20 Jan 2025	2	2
21 Jan 2025	1	1
22 Jan 2025	2	1
23 Jan 2025	45	41
10 Feb 2025	1	0
11 Feb 2025	32	32
12 Feb 2025	10	10
13 Feb 2025	30	29
10 Mar 2025	2	2
11 Mar 2025	9	9
12 Mar 2025	228	225
13 Mar 2025	24	23
31 Mar 2025	3	3
1 Apr 2025	35	35
2 Apr 2025	251	248
3 Apr 2025	62	61
5 May 2025	5	4
6 May 2025	10	10
7 May 2025	220	220
8 May 2025	103	103
21 May 2025	2	2
22 May 2025	53	52
16 Jun 2025	2	2
17 Jun 2025	41	41
18 Jun 2025	91	91
19 Jun 2025	87	87
7 Jul 2025	1	1
8 Jul 2025	55	55
9 Jul 2025	134	134
10 Jul 2025	36	36
8 Sept 2025	1	1
9 Sept 2025	101	101
10 Sept 2025	34	34
11 Sept 2025	69	69
6 Oct 2025	2	2
7 Oct 2025	5	5
8 Oct 2025	55	55
9 Oct 2025	65	65
20 Oct 2025	3	3
21 Oct 2025	13	13
22 Oct 2025	186	186
23 Oct 2025	55	55
13 Nov 2025	267	267
24 Nov 2025	3	3
25 Nov 2025	75	75
26 Nov 2025	100	100
27 Nov 2025	125	125
15 Dec 2025	4	4
16 Dec 2025	66	66
17 Dec 2025	43	43
18 Dec 2025	42	42

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
Select	Member	Group	Country	Agreement	Baseline
Select Mirosława NYKIEL	Mirosława NYKIEL	EPP	Poland	98 % of 5 236 shared	89 %
Select Andrzej BUŁA	Andrzej BUŁA	EPP	Poland	98 % of 5 367 shared	89 %
Select Krzysztof BREJZA	Krzysztof BREJZA	EPP	Poland	98 % of 5 431 shared	89 %
Select Jagna MARCZUŁAJTIS-WALCZAK	Jagna MARCZUŁAJTIS-WALCZAK	EPP	Poland	98 % of 5 484 shared	89 %
Select Dariusz JOŃSKI	Dariusz JOŃSKI	EPP	Poland	97 % of 5 731 shared	89 %
Select Andrzej HALICKI	Andrzej HALICKI	EPP	Poland	97 % of 5 335 shared	89 %
Select Michał WAWRYKIEWICZ	Michał WAWRYKIEWICZ	EPP	Poland	97 % of 5 330 shared	89 %
Select Bartosz ARŁUKOWICZ	Bartosz ARŁUKOWICZ	EPP	Poland	97 % of 5 594 shared	89 %
Select Magdalena ADAMOWICZ	Magdalena ADAMOWICZ	EPP	Poland	97 % of 5 501 shared	89 %
Select Elżbieta Katarzyna ŁUKACIJEWSKA	Elżbieta Katarzyna ŁUKACIJEWSKA	EPP	Poland	97 % of 5 573 shared	89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
Select	Member	Group	Country	Agreement	Baseline
Select Urmas PAET	Urmas PAET	Renew	Estonia	84 % of 5 292 shared	82 %
Select Dan BARNA	Dan BARNA	Renew	Romania	84 % of 5 142 shared	82 %
Select Sophie WILMÈS	Sophie WILMÈS	Renew	Belgium	84 % of 4 038 shared	82 %
Select Hilde VAUTMANS	Hilde VAUTMANS	Renew	Belgium	84 % of 5 672 shared	82 %
Select Eugen TOMAC	Eugen TOMAC	Renew	Romania	83 % of 4 237 shared	82 %
Select Ivars IJABS	Ivars IJABS	Renew	Latvia	83 % of 4 485 shared	82 %
Select Katri KULMUNI	Katri KULMUNI	Renew	Finland	83 % of 4 625 shared	82 %
Select Dan NICA	Dan NICA	S&D	Romania	83 % of 3 531 shared	75 %
Select Benoit CASSART	Benoit CASSART	Renew	Belgium	83 % of 5 360 shared	82 %
Select Dainius ŽALIMAS	Dainius ŽALIMAS	Renew	Lithuania	83 % of 5 454 shared	82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
Body	Role	From	To
Committee on the Environment, Climate and Food SafetyENVI Committee	Member	20 Jan 2025	now
Committee on Women’s Rights and Gender EqualityFEMM Committee	Member	19 Jul 2024	now
Committee on Public HealthSANT Committee	Substitute	23 Jan 2025	now
Delegation for relations with CanadaD-CA Delegation	Member	19 Sept 2024	now
Delegation for Northern cooperation and for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary CommitteeDEEA Delegation	Substitute	19 Sept 2024	now
Committee on the Environment, Public Health and Food SafetyENVI Committee	Member	19 Jul 2024	19 Jan 2025
Subcommittee on Public HealthSANT Subcommittee	Substitute	19 Jul 2024	19 Jan 2025

Show all 7 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
Dossier	Role	Committee	Date
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)	Shadow rapporteur for an opinion	ENVI	10 Apr 2026
Impact of social media and the online environment on young people	Shadow rapporteur for an opinion	FEMM	26 Sept 2025
No dossier named	Vice-President		9 Jul 2024

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

194 contributions recorded, 12 written statements; 4 on behalf of their group; 65 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
Date	Debate	Kind	Verbatim
16 Sept 2026	Approval of the minutes of the sitting	Speech	Read
16 Sept 2026	Agenda of the next sitting	Speech	Read
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure (A10-0212/2026 - Rasa Juknevičienė)	Speech	Read
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure (A10-0212/2026 - Rasa Juknevičienė)	Speech	Read
16 Sept 2026	Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) (A10-0273/2025 - Sven Mikser, Pierfrancesco Maran, Aura Salla)	Speech	Read
16 Sept 2026	Acceleration of permit-granting for defence readiness projects (Omnibus V) (A10-0271/2025 - Lucia Yar, Henrik Dahl)	Speech	Read
16 Sept 2026	Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) (A10-0273/2025 - Sven Mikser, Pierfrancesco Maran, Aura Salla)	Speech · 1 min	Read
16 Sept 2026	Oral explanations of votes (Rule 201)	Speech	Read
16 Sept 2026	Devastating floods in Nepal (debate)	Speech	Read
16 Sept 2026	Devastating floods in Nepal (debate)	Speech · 1 min	Read

Show all 40 recent contributions

Questions and motions, 25

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
Date	Title	Kind	Answer
10 Sept 2026	Sexual exploitation of children in travel and tourism: closing the gaps beyond the EU’s borders E-10-2026-003633	Written questionwith 11 co-authors	Not yet answered
13 Jul 2026	Missing and runaway children as an indicator of violence, abuse and grooming E-10-2026-002868	Written questionwith 15 co-authors	Not yet answered
29 Jun 2026	Protecting minors online from manipulation, bullying and grooming E-10-2026-002680	Written questionwith 9 co-authors	11 Sept 2026
17 Jun 2026	Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516	Written questionwith 17 co-authors	24 Aug 2026
9 Jun 2026	Chinese tomato concentrate imports: protecting EU producers and food security P-10-2026-002375	Priority written questionwith 23 co-authors	13 Jul 2026
6 May 2026	Continuity of tertiary education for pregnant women and women with children E-10-2026-001857	Written questionwith 46 co-authors	3 Jul 2026
27 Apr 2026	MOTION FOR A RESOLUTION on the need for targeted criminal provisions and platforms’ responsibility to effectively address cyberbullying and online harassment B-10-2026-0235	Motion for a resolutionwith 11 co-authors	—
17 Apr 2026	The need for targeted criminal provisions on cyberbullying and online harassment and platforms’ responsibility to effectively address these issues O-10-2026-000018	Oral questionwith 11 co-authors	Not yet answered
11 Mar 2026	Financing EU priorities in a sustainable, predictable and resilient way through a new EU own resource from the online gambling and betting services sector O-10-2026-000014	Oral questionwith 42 co-authors	Not yet answered
24 Feb 2026	Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762	Written questionwith 20 co-authors	16 Apr 2026

Show all 25 questions and motions

Amendments tabled in committee, 41

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
Date	Text amended	Committee	Amendments
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953	CJ53	1
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935	CJ53	6
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936	CJ53	14
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937	CJ53	21
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938	CJ53	8
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939	CJ53	2
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005	CJ53	5
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932	CJ53	5
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934	CJ53	5
26 Jun 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) ENVI-AM-790222	ENVI	16

Show all 41 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

Group European People’s Party EPP · Centre-right · Christian democracy, conservatism

National delegation

Delegation Poland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/members/197525?period=2025&rows=all
Official source: Member’s profile, European Parliament
Data source: EP Open Data: member record
Licensed CC BY 4.0.
Data version: data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved: 25 September 2026

Cite as

EU Parl Watch Research (2026). “Ewa KOPACZ”. Member record. memberId 197525. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197525?period=2025&rows=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197525. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197525?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.

BibTeX

@misc{epw-member-197525,
  author = {{EU Parl Watch Research}},
  title = {{Ewa KOPACZ}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197525?period=2025&rows=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/197525?period=2025&rows=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197525. Official source: https://www.europarl.europa.eu/meps/en/197525. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}